Community/Retail

A federal appropriations bill will not include bipartisan provision that would have required drug manufacturers to be more transparent with costs to consumers after it was blocked by House Republicans.

What's the best advice for a patient who is interested in a vaccine against shingles?

A coalition of health care industry leaders hosted a meeting Thursday in Washington, DC, to examine how to address this problem.

Mylan’s new Dalfampridine Extended-Release Tablets, 10 mg, an authorized generic version of Acorda's Ampyra® is being marketed to treat adult patients with multiple sclerosis.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Health, United States, 2017 includes an in-depth special feature that discusses mortality in America.

The social media post noted that grief counselors will be made available to associates and "will remain available as long as they are needed."

The FDA did not identify any new or unexpected safety findings with pimavanserin (Nuplazid), nor findings that are inconsistent with the established safety profile currently described in the drug label, in an analysis of all available data.

In this clip, Troy Trygstad, Editor in Chief of Pharmacy Times, interviews Jack Vallandinham, the owner of Jack’s Corner Drug Store in Sigourney, Iowa. Jack explains how he works with other health care providers and gets to know patient needs in order to provide them with optimal care.

A global phase 3a trial successfully demonstrated greater reductions in HbA1c and body weight with a oral semaglutide drug treatment than with dulaglutide, as well as a a comparable number of adverse events in 458 Japanese adults with type 2 diabetes between these medications.

Implementation of universal health care is part of the Sustainable Development Goals (SDGs), which are new targets signed by 193 United Nations member states to improve health and development by 2030.

The American Hospital Association and individual hospitals have initiated new principles for ensuring good stewardship of the 340B drug program.

According to evidence presented at trial, from approximately December 2011 to August 2015, Ramirez, Shepherd and Nwoko conspired and schemed to defraud Medicare out of payments for medical services.

NCPA officials applaud passage.

Pharmacies closed by Hurricane Florence are working to re-open, as customers are being directed to open stores, and some pharmacies are going even further to assist staff and customers as they recover from the storm's impact.

Almirall has received European Commission approval for its plaque psoriasis treatment tildrakizumab (Ilumetri).

As medication experts, pharmacists are integral to team-based care, providing the requisite knowledge for medication therapy management, as well as initiating, modifying and monitoring drug therapy to benefit patient care.

Researchers have identified a potential point of intervention that could prevent the progression of liver damage to cancer.

The vaginal inserts can reduce symptoms such as hot flashes and mood swings.

Can you solve the pharmaceutical mystery? Each week, a new case study is presented.

Officials with the FDA have approved fremanezumab-vfrm (Ajovy, Teva) for the preventive treatment of migraine in adults.

As growing levels of antibiotic resistance continues to concern health care professionals, the results of a recent study suggest that giving daily probiotic supplements to children can reduce their likelihood of requiring antibiotics.

Some researchers propose that vasomotor symptoms may signal physiologic processes that might be associated with other related systemic health diagnoses.

Presenters at the International Pharmaceutical Federation (FIP) World Congress in Glasgow, Scotland identified the current landscape of Hepatitis C, how pharmacists can position themselves to aid in point of care testing, and ways to better educate patients and providers.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Officials with the FDA have approved AstraZeneca’s moxetumomab pasudotox-tdfk (Lumoxiti) injection for intravenous use for the treatment of adult patients with relapsed or refractory hairy cell leukemia who have received at least 2 prior systemic therapies.

A second unexpected impurity was shown in 3 lots of Torrent Pharmaceuticals’ recalled drug products during an ongoing FDA investigation.

The FDA has accepted for review Regeneron Pharmaceuticals’ supplemental Biologics License Application of aflibercept (EYLEA Injection) to treat diabetic retinopathy.

A recent survey evaluated the baseline knowledge of licensed pharmacists with regard to common pet toxins.

A study examined whether silymarin, is an active extract of milk thistle, has a therapeutic effect and can improve hepatic enzyme measures.